John S. Wittenborn

3.7k total citations · 2 hit papers
45 papers, 2.3k citations indexed

About

John S. Wittenborn is a scholar working on Ophthalmology, Epidemiology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, John S. Wittenborn has authored 45 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Ophthalmology, 19 papers in Epidemiology and 15 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in John S. Wittenborn's work include Retinal Diseases and Treatments (16 papers), Retinal Imaging and Analysis (15 papers) and Ophthalmology and Visual Impairment Studies (9 papers). John S. Wittenborn is often cited by papers focused on Retinal Diseases and Treatments (16 papers), Retinal Imaging and Analysis (15 papers) and Ophthalmology and Visual Impairment Studies (9 papers). John S. Wittenborn collaborates with scholars based in United States, Switzerland and India. John S. Wittenborn's co-authors include David B. Rein, Gretchen A Stevens, Steven Wiersma, Bryce D. Smith, Jinan Saaddine, Thomas J. Hoerger, Sarah B. Lesesne, Cindy M. Weinbaum, John W. Ward and Elizabeth A. Lundeen and has published in prestigious journals such as Annals of Internal Medicine, Hepatology and Diabetes Care.

In The Last Decade

John S. Wittenborn

43 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The global burden of hepatitis E virus genotypes 1 and 2 in 2005

2011 533 citations David B. Rein, Gretchen A Stevens et al. Hepatology profile →
Prevalence of Age-Related Macular Degeneration in the US in 2019

2022 132 citations David B. Rein, John S. Wittenborn et al. JAMA Ophthalmology profile →

Peers

John S. Wittenborn

HEPAT

EPIDE

OPHTH

RNMI

Piergiorgio Duca Italy

John Forsythe United Kingdom

Andrew Atkinson Switzerland

Jason V. Baker United States

Yung‐Feng Yen Taiwan

Robert Wyllie United States

Daniel Grima Canada

Axel Heinemann Germany

J E Siegel United States

Nicole S. Erler Netherlands

Piergiorgio Duca Italy

John S. Wittenborn

455 ×0.4

HEPAT

1.1k ×1.3

EPIDE

141 ×0.2

OPHTH

328 ×0.8

RNMI

212 ×0.6

Citations per year, relative to John S. Wittenborn John S. Wittenborn (= 1×) peers Piergiorgio Duca

Countries citing papers authored by John S. Wittenborn

Since Specialization

Citations

This map shows the geographic impact of John S. Wittenborn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John S. Wittenborn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John S. Wittenborn more than expected).

Fields of papers citing papers by John S. Wittenborn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John S. Wittenborn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John S. Wittenborn. The network helps show where John S. Wittenborn may publish in the future.

Co-authorship network of co-authors of John S. Wittenborn

This figure shows the co-authorship network connecting the top 25 collaborators of John S. Wittenborn. A scholar is included among the top collaborators of John S. Wittenborn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John S. Wittenborn. John S. Wittenborn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Burke-Conte, Zeb, John S. Wittenborn, Jinan Saaddine, et al.. (2024). Prevalence of Glaucoma Among US Adults in 2022. JAMA Ophthalmology. 142(11). 1046–1046. 6 indexed citations

Brault, Matthew W., John S. Wittenborn, & David B. Rein. (2024). Behavioral Risk Factor Surveillance System and American Community Survey Estimates of Vision Difficulty Prevalence. JAMA Ophthalmology. 142(8). 768–768.

Wittenborn, John S., Aaron Lee, Elizabeth A. Lundeen, et al.. (2023). Validity of Administrative Claims and Electronic Health Registry Data From a Single Practice for Eye Health Surveillance. JAMA Ophthalmology. 141(6). 534–534. 3 indexed citations

Wittenborn, John S., et al.. (2023). A Mixed-Methods Approach for Evaluating Implementation Processes and Program Costs for a Hypertension Management Program Implemented in a Federally Qualified Health Center. Prevention Science. 25(S1). 10–21. 1 indexed citations

Wittenborn, John S., Aaron Lee, Elizabeth A. Lundeen, et al.. (2023). Comparing Telephone Survey Responses to Best-Corrected Visual Acuity to Estimate the Accuracy of Identifying Vision Loss: Validation Study. JMIR Public Health and Surveillance. 9. e44552–e44552. 3 indexed citations

Rein, David B., John S. Wittenborn, Ping Zhang, et al.. (2021). The Economic Burden of Vision Loss and Blindness in the United States. Ophthalmology. 129(4). 369–378. 68 indexed citations

Rein, David B., Phoebe A. Lamuda, John S. Wittenborn, et al.. (2020). Vision Impairment and Blindness Prevalence in the United States. Ophthalmology. 128(1). 15–27. 24 indexed citations

Lundeen, Elizabeth A., John S. Wittenborn, Stephen R. Benoit, & Jinan Saaddine. (2019). Disparities in Receipt of Eye Exams Among Medicare Part B Fee-for-Service Beneficiaries with Diabetes — United States, 2017. MMWR Morbidity and Mortality Weekly Report. 68(45). 1020–1023. 30 indexed citations

Rein, David B., et al.. (2015). The Cost-effectiveness, Health Benefits, and Financial Costs of New Antiviral Treatments for Hepatitis C Virus. Clinical Infectious Diseases. 61(2). 157–168. 105 indexed citations

10.

Wittenborn, John S., Xinzhi Zhang, Wesley L. Crouse, et al.. (2013). The Economic Burden of Vision Loss and Eye Disorders among the United States Population Younger than 40 Years. Ophthalmology. 120(9). 1728–1735. 129 indexed citations

11.

Hoerger, Thomas J., John S. Wittenborn, Xiaohui Zhuo, et al.. (2012). Cost-Effectiveness of Screening for Microalbuminuria among African Americans. Journal of the American Society of Nephrology. 23(12). 2035–2041. 36 indexed citations

12.

Rein, David B., Bryce D. Smith, John S. Wittenborn, et al.. (2012). The Cost-Effectiveness of Birth-Cohort Screening for Hepatitis C Antibody in U.S. Primary Care Settings. Annals of Internal Medicine. 156(4). 263–270. 239 indexed citations

13.

Rein, David B., et al.. (2011). The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology. 55(4). 988–997. 533 indexed citations breakdown →

14.

Wittenborn, John S. & David B. Rein. (2010). Cost-Effectiveness of Glaucoma Interventions in Barbados and Ghana. Optometry and Vision Science. 88(1). 155–163. 32 indexed citations

15.

Hoerger, Thomas J., John S. Wittenborn, Joel E. Segel, et al.. (2010). A Health Policy Model of CKD: 1. Model Construction, Assumptions, and Validation of Health Consequences. American Journal of Kidney Diseases. 55(3). 452–462. 70 indexed citations

16.

Hoerger, Thomas J., John S. Wittenborn, Joel E. Segel, et al.. (2010). A Health Policy Model of CKD: 2. The Cost-Effectiveness of Microalbuminuria Screening. American Journal of Kidney Diseases. 55(3). 463–473. 101 indexed citations

17.

Rein, David B., John S. Wittenborn, Cindy M. Weinbaum, et al.. (2010). Forecasting the morbidity and mortality associated with prevalent cases of pre-cirrhotic chronic hepatitis C in the United States☆☆☆. Digestive and Liver Disease. 43(1). 66–72. 171 indexed citations

18.

Rein, David B., John S. Wittenborn, Paul P. Lee, et al.. (2009). The Cost-effectiveness of Routine Office-based Identification and Subsequent Medical Treatment of Primary Open-Angle Glaucoma in the United States. Ophthalmology. 116(5). 823–832. 58 indexed citations

19.

Rein, David B., Jinan Saaddine, John S. Wittenborn, et al.. (2007). Cost-effectiveness of Vitamin Therapy for Age-Related Macular Degeneration. Ophthalmology. 114(7). 1319–1326. 30 indexed citations

20.

Finkelstein, Eric, John S. Wittenborn, & Rosanne P. Farris. (2004). Evaluation of Public Health Demonstration Programs: The Effectiveness and Cost-Effectiveness of WISEWOMAN. Journal of Women s Health. 13(5). 625–633. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact